For the 17mg/mL concentration, 2.5mg equals approximately 14.7 units (0.147 mL)
Tirzepatide is a dual-action medication that targets both GLP-1 and GIP receptors, which is why clinical trials have shown it producing greater average weight loss than semaglutide alone
Youll typically get a response within 24-48 hours
A 2015 meta-analysis highlights that bone loss is a frequently overlooked consequence of aggressive weight interventionsparticularly when they arent paired with adequate calcium, vitamin D, and resistance training
Semaglutide, Dulaglutide, Liraglutide, and Tirzepatide dominate the GLP-1 agonist market
Slow-digesting, high-fiber carbohydrates may help stabilize blood sugar levels and reduce spikes